Non-invasive quantifcation and characterization of coronary plaque

Autor: Dalager, M. G., Hans Erik Bøtker, Morten Bøttcher, Ivanc, T. B., Olszewski, M. E., Norrgren, K.

Publikováno v: Aarhus University

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::311ba6655e72e564de47905313d977d8
https://pure.au.dk/portal/en/publications/noninvasive-quantifcation-and-characterization-of-coronary-plaque(5d53dad6-6c56-4f94-8046-7772b538a360).html

A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis:Ineffectiveness in head‐and‐neck dermatitis

Autor: Ida Vittrup, Niels Steen Krogh, Henrik Hedegaard Pliess Larsen, Jesper Elberling, Lone Skov, Kristina Sophie Ibler, Gregor B. E. Jemec, Charlotte G. Mortz, Rasmus Overgaard Bach, Carsten Bindslev‐Jensen, Maiken Glud Dalager, Alexander Egeberg, Tove Agner, Mette Deleuran, Christian Vestergaard, Jacob Pontoppidan Thyssen

Publikováno v: Vittrup, I, Krogh, N S, Larsen, H H P, Elberling, J, Skov, L, Ibler, K S, Jemec, G B E, Mortz, C G, Bach, R O, Bindslev-jensen, C, Dalager, M G, Egeberg, A, Agner, T, Deleuran, M, Vestergaard, C & Thyssen, J P 2023, ' A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis : Ineffectiveness in head-and-neck dermatitis ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 5, pp. 1046-1055 . https://doi.org/10.1111/jdv.18849
Vittrup, I, Krogh, N S, Larsen, H H P, Elberling, J, Skov, L, Ibler, K S, Jemec, G B E, Mortz, C G, Bach, R O, Bindslev-Jensen, C, Dalager, M G, Egeberg, A, Agner, T, Deleuran, M, Vestergaard, C & Thyssen, J P 2023, ' A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis : Ineffectiveness in head-and-neck dermatitis ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 5, pp. 1046-1055 . https://doi.org/10.1111/jdv.18849
Vittrup, I, Elberling, J, Skov, L, Ibler, K S, Jemec, G B E, Mortz, C G, Bindslev-Jensen, C, Agner, T, Deleuran, M, Vestergaard, C & Thyssen, J P 2023, ' A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis : ineffectiveness in head-and-neck dermatitis ', Journal of the European Academy of Dermatology and Venereology : JEADV . https://doi.org/10.1111/jdv.18849

BackgroundEvaluation of effectiveness and safety of new systemic treatments for atopic dermatitis (AD) after approval is important. There are few published data exceeding 52-week therapy with dupilumab.ObjectivesTo examine the safety, effectiveness a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4cd9d8884f2d9344455fb47022af7be
https://curis.ku.dk/ws/files/356555011/Acad_Dermatol_Venereol_2023_Vittrup_A_nationwide_104_weeks_real_world_study_of_dupilumab_in_adults_with_atopic.pdf

Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment

Autor: Nandy, Anirban, Tankisi, Hatice, Krøigård, Anne Bruun, Dalager, Maiken Glud, Hvidbjerg, Marie Skov, Schrøder, Henrik Daa, Obál, Izabella

Publikováno v: Nandy, A, Tankisi, H, Krøigård, A B, Dalager, M G, Hvidbjerg, M S, Schrøder, H D & Obál, I 2023, ' Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment ', BMC Neurology, vol. 23, no. 1, 233 . https://doi.org/10.1186/s12883-023-03283-7

BackgroundSporadic late onset nemaline myopathy is a rare, progressive muscle disease, presenting in adulthood, mainly affecting proximal limb and bulbar muscles. Muscle biopsies show characteristic nemaline rods. The putative mechanism is considered

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0b14183404b29f2afb0dd2acd42b6fb9
https://pure.au.dk/portal/da/publications/sporadic-late-onset-nemaline-myopathy-with-concurrent-dermatological-symptoms-responding-to-immunosuppressive-treatment(8f407c1a-1bb8-47bc-99d0-e4647d2f8ce9).html

Imaging atherosclerotic plaques by cardiac computed tomography in vitro:Impact of contrast type and acquisition protocol

Autor: Søren Dalager, Maiken Glud Dalager, Gratien Andersen, Morten Bøttcher, Hans Erik Bøtker, Erik Morre Pedersen, Jesper Thygesen

Publikováno v: Dalager, M G, Bøttcher, M, Dalager, S, Andersen, G, Thygesen, J, Pedersen, E M & Bøtker, H E 2011, ' Imaging atherosclerotic plaques by cardiac computed tomography in vitro : Impact of contrast type and acquisition protocol ', Investigative Radiology, vol. 46, no. 12, pp. 790-795 . https://doi.org/10.1097/RLI.0b013e31822b122e
Dalager, M G, Bøttcher, M, Dalager, S, Andersen, G, Thygesen, J, Pedersen, E M & Bøtker, H E 2011, ' Imaging atherosclerotic plaques by cardiac computed tomography in vitro: impact of contrast type and acquisition protocol ', Investigative Radiology, vol. 46, no. 12, pp. 790-5 . https://doi.org/10.1097/RLI.0b013e31822b122e

Objective: Noninvasive contrast-enhanced coronary computed tomography (CT) angiography enables distinction between calcified and noncalcified atherosclerotic plaques. However, separation of noncalcified plaques into rupture prone lipid-rich and stabl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45fa3ba9d0c812c932d7cd87bdfdb20
https://pure.au.dk/portal/da/publications/imaging-atherosclerotic-plaques-by-cardiac-computed-tomography-in-vitro(70652a59-4b49-43cb-97f3-f745af5944c3).html

Machine Learning Model for Predicting Outcomes of Biologic Therapy in Psoriasis

Autor: Amy X. Du, Zarqa Ali, Kawa K. Ajgeiy, Maiken G. Dalager, Tomas N. Dam, Alexander Egebjerg, Christoffer V. S. Nissen, Lone Skov, Simon Francis Thomsen, Sepideh Emam, Robert Gniadecki

Publikováno v: Du, A X, Ali, Z, Ajgeiy, K K, Dalager, M G, Dam, T N, Egebjerg, A, Nissen, C V S, Skov, L, Thomsen, S F, Emam, S & Gniadecki, R 2023, ' Machine Learning Model for Predicting Outcomes of Biologic Therapy in Psoriasis ', Journal of the American Academy of Dermatology, vol. 88, no. 6, pp. 1364-1367 . https://doi.org/10.1016/j.jaad.2022.12.046

BackgroundBiological agents used for the therapy of psoriasis lose efficacy over time, which leads to discontinuation of the drug. Optimization of long-term biologic treatment is an area of medical need but there are currently no prediction tools for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4040ed647350c9349b41a50e179a59
https://doi.org/10.1101/2021.12.05.21267219